中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

1638 records (took 0.035 seconds)

    PROCESSING DATA FROM A MEDICAL ANALYZER
    91.
    发明申请
    PROCESSING DATA FROM A MEDICAL ANALYZER 有权

    公开(公告)号：US20210295958A1

    公开(公告)日：2021-09-23

    申请号：US17201393

    申请日：2021-03-15

    Applicant: Roche Diagnostics Operations, Inc.

    Inventor： Stephen Martin ,  Alexandra Paun ,  Jakub Winiarz

    IPC: G16H10/40 ,  G16H10/20 ,  G06F16/2457 ,  G06F16/28

    Abstract: A method for operating a data processing agent for processing data from an automated medical sample analyzer is presented. The method comprises receiving at least one automated analyzer status datum transmitted from at least one automated analyzers in a medical sample analysis system to the data processing agent, wherein the automated analyzer status data is generated by the at least one automated analyzer in response to an automated analyzer condition detected by an automated analyzer, receiving at least one annotation datum at the data processing agent, associating at least one automated analyzer status datum with at least one annotation datum using the processing agent to generate an automated analyzer system data record, and outputting the automated analyzer system data record from the data processing agent, wherein the automated analyzer system data record comprises at least one automated analyzer device status datum associated with at least one annotation datum.

    METHOD FOR DETERMINING CHARACTERISTICS OF A SAMPLE CONTAINER IN AN IN-VITRO DIAGNOSTICS SYSTEM, ANALYZING DEVICE, AND IN-VITRO DIAGNOSTICS SYSTEM
    94.
    发明申请
    METHOD FOR DETERMINING CHARACTERISTICS OF A SAMPLE CONTAINER IN AN IN-VITRO DIAGNOSTICS SYSTEM, ANALYZING DEVICE, AND IN-VITRO DIAGNOSTICS SYSTEM 有权

    公开(公告)号：US20210287370A1

    公开(公告)日：2021-09-16

    申请号：US17197655

    申请日：2021-03-10

    Applicant: Roche Diagnostics Operations, Inc.

    Inventor： Emad Sarofim

    IPC: G06T7/00 ,  G06T7/11

    Abstract: A method for determining sample container characteristics is presented. The method comprises providing first image data representing a first image of a sample container in a first scenario, wherein in the first scenario, a first illumination condition comprising a sample container background illumination is applied to the sample container; providing second image data representing a second image of the sample container in a second scenario, wherein in the second scenario, a second illumination condition different from the first is applied to the sample container; determining a mask from the first image that indicates a sub-image section of the first image comprising a sample container representation in the first image; determining sub-image data from the second image containing a sample container representation in the second image by applying the mask to the second image; and determining the sample container characteristics from an image data analysis comprising image sub-image data data analysis.

    Method and device for separating metabolites or stereoisomers
    95.
    发明授权
    Method and device for separating metabolites or stereoisomers 有权

    公开(公告)号：US11099154B2

    公开(公告)日：2021-08-24

    申请号：US15366695

    申请日：2016-12-01

    Applicant: Roche Diagnostics Operations, Inc. ,  Owlstone Medical Limited

    Inventor： Uwe Kobold ,  Roland Thiele ,  Noah Weiss ,  Lauren Brown

    IPC: G01N27/624 ,  G01N33/82 ,  G01N33/487 ,  H01J49/00

    Abstract: A method of quantifying the amount of at least two analytes A1 and A2 involving (a) adding at least one salt (S) to at least a portion (P1) of the sample comprising the at least two analytes A1 and A2, (b) ionizing at least a portion of the sample according to (a) thereby forming an analyte flow comprising the analytes A1 and A2 in ionized form, (c) separating the ionized analytes A1 and A2 from each other by using at least one ion mobility separator (124), wherein the analyte flow according to (b) at least partially passes through the ion mobility separator (124), and (d) quantifying the amount of the separated ionized analytes obtained according to (c), wherein A1 is a pharmaceutically active compound C or derivative thereof and A2 is a metabolite or stereoisomer of C.

Patent Agency Ranking